You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Moodys
Express Scripts
AstraZeneca
Medtronic

Last Updated: April 5, 2020

DrugPatentWatch Database Preview

QUARTETTE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Quartette, and what generic alternatives are available?

Quartette is a drug marketed by Teva Branded Pharm and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-four patent family members in thirteen countries.

The generic ingredient in QUARTETTE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

US ANDA Litigation and Generic Entry Outlook for Quartette

There have been two patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.

There are two tentative approvals for the generic drug (ethinyl estradiol; levonorgestrel), which indicates the potential for near-term generic launch.

Indicators of Generic Entry

< Available with Subscription >

  Start Trial

Drug patent expirations by year for QUARTETTE
Drug Prices for QUARTETTE

See drug prices for QUARTETTE

Drug Sales Revenue Trends for QUARTETTE

See drug sales revenues for QUARTETTE

Recent Litigation for QUARTETTE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Teva Women's Health, Inc. v. Famy Care Ltd.2014-12-05
Teva Women's Health, Inc. v. Famy Care Ltd.2014-07-02

See all QUARTETTE litigation

Synonyms for QUARTETTE
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-, mixt. with (17-alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-(+-)-, mixt. with (17-alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-(+-)-,mixt. with (17-alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
39366-37-5
8056-51-7
Adepal
AG 200-15
AG200-15
aless
Alesse
Alesse 28
Altavera
Anna
Anteovin
aviane
AVIANE-21
Aviane-21Fe
AVIANE-28
Biphasil
Biphasil 21
Biphasil 28
C21H28O2.C20H24O2
CCRIS 7261
CRYSELLE
dl-Norgestrel mixed with ethinylestradiol
DTXSID90192569
Duoluton
Ediwal
Elifemme
ENPRESSE-21
ENPRESSE-28
Ethinyl estradiol mixed with norgestrel
Ethinyl estradiol mixture with levonorgestrel
Ethinyl estradiol mixture with norgestrel
ETHINYL ESTRADIOL-NORGESTREL COMBINATION
ethinyl estradiol, levonorgestrel drug combination
Ethinyl estradiol/levonorgestrel
Ethinylestradiol - levonorgestrel mixt
Ethinylestradiol - levonorgestrel mixt.
Ethinylestradiol mixed with dl-norgestrel
Ethinylestradiol mixture with Levonorgestrel
Ethinyloestradiol mixed with norgestrel
Eugynon
Eugynon 30
Femenal
Follimin
Follinett
Follinyl
Gravistat
Gynatrol
Introvale
Jolessa
LESSINA-21
LESSINA-28
LEVLITE
Levonest
Levonorgestrel - ethynylestradiol mixt
Levonorgestrel - ethynylestradiol mixt.
Levonorgestrel and Ethinyl Estradiol
Levonorgestrel and Ethinyl Estradiol tablets
Levonorgestrel-ethinyl estradiol mixt
Levonorgestrel-ethinyl estradiol mixt.
Levonorgestrel, ethinyl estradiol
Levonorgestrel/ethinyl estradiol
Levora
LEVORA 0.15/30-21
LEVORA 0.15/30-28
Lo-Femenal
LO/OVRAL-28
LOC 31
LOC 31A
Logynon
Loseasonique
Low-ogestrel
LOW-OGESTREL-21
LOW-OGESTREL-28
LS-62088
LS-62092
Lybrel
Marlissa
Microgynon
Microgynon 30
Microvlar 30
Minidril
Minigynon
Minisiston
Neogynon
Neovlar
Neovletta
NORDETTE-21
NORDETTE-28
Nordiol
Nordiol-28
Norgestrel and Ethinyl Estradiol
Norgestrel mixed with ethinyl estradiol
Norgestrel mixed with ethinyloestradiol
Norgestrel-ethinyl estradiol
Norgestrel-Ethinyl Estradiol Combination
Norgestrel-ethynylestradiol mixt
Norgestrel-ethynylestradiol mixt.
OGESTREL 0.5/50-21
OGESTREL 0.5/50-28
Orasecron
Ovidon
Ovral
Ovral 21
Ovral 28
Ovral L
OVRAL-28
Ovran
Ovranett
PC 4 (contraceptive)
Pearl Oral Contraceptive
Portia
PORTIA-21
PORTIA-28
PREVEN EMERGENCY CONTRACEPTIVE KIT
Primovlar
Pro-Duosterone
Quasense
Rigevidon
SCHEMBL4451192
Schering PC 4
Sequilar
Sequilarum
Sequostat
SH 71121
SH D00264A
SHB 261AB
SHB 264AB
Sronyx
Stederil 30
Stediril
Stediril D
Tri-Regol
Trigynon
Trikvilar
Trinordiol
Triphasil-21
TRIPHASIL-28
Triquilar
Trisiston
Trisistone R
Trisistone-R
TRIVORA-21
TRIVORA-28
Twirla
Vienva
WL 33
WY-E 104
Paragraph IV (Patent) Challenges for QUARTETTE
Tradename Dosage Ingredient NDA Submissiondate
QUARTETTE TABLET;ORAL ethinyl estradiol; levonorgestrel 204061 2013-07-10

US Patents and Regulatory Information for QUARTETTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm QUARTETTE ethinyl estradiol; levonorgestrel TABLET;ORAL 204061-001 Mar 28, 2013 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Teva Branded Pharm QUARTETTE ethinyl estradiol; levonorgestrel TABLET;ORAL 204061-001 Mar 28, 2013 AB RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for QUARTETTE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0771217 07C0001 France   Start Trial PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804
1453521 15C0050 France   Start Trial PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129
0771217 CA 2006 00038 Denmark   Start Trial PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Moodys
Express Scripts
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.